Holen Sie sich die Stockscreener-App
13.36
0.15%
0.02
Handel nachbörslich:
13.35
-0.010
-0.07%
Schlusskurs vom Vortag:
$13.34
Offen:
$13.37
24-Stunden-Volumen:
3.53M
Relative Volume:
0.42
Marktkapitalisierung:
$3.51B
Einnahmen:
$6.16B
Nettoeinkommen (Verlust:
$246.00M
KGV:
14.23
EPS:
0.9387
Netto-Cashflow:
$708.00M
1W Leistung:
-0.52%
1M Leistung:
+0.53%
6M Leistung:
+75.79%
1J Leistung:
+44.90%
1-Tages-Spanne:
$13.35
$13.40
1-Wochen-Bereich:
$13.34
$13.44
52-Wochen-Spanne:
$5.69
$13.48
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, MRK, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.36 | 3.50B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,082.20 | 985.37B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
223.51 | 542.42B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
212.93 | 384.67B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
115.17 | 293.22B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
179.71 | 287.95B | 60.48B | 10.40B | 8.05B | 3.3297 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-10-27 | Herabstufung | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Overweight |
| 2023-03-16 | Eingeleitet | Raymond James | Outperform |
| 2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-01 | Eingeleitet | BofA Securities | Buy |
| 2021-07-22 | Eingeleitet | Citigroup | Buy |
| 2021-06-15 | Eingeleitet | JP Morgan | Neutral |
| 2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
Sun Pharma, Organon filed HSR May 21, waiting period expires June 22 - MLex
Organon (OGN) to be Acquired by Sun Pharma for $14.00 Cash per Share - Stock Titan
Sun Pharma bought the dip in its $11.7B Organon deal. Just not the right kind of dip - The Ken
OGNOrganon & Co Stock Price and Quote - Finviz
Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal - DD News
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
Top Organon & Co. (OGN) Competitors 2026 - MarketBeat
Organon (OGN) Holds Near Support at $13.35 as Stock ConsolidatesInsider Selling Alerts - thelegaladvocate.com
Organon & Co stock (US68622V1061): Shares trade quietly as investors await next catalysts - AD HOC NEWS
Organon & Co is the best performing healthcare stock in April - MSN
Organon & Co(OGN) Stock Options Chain | Quotes & News - Moomoo
Organon Stock Holds Steady Near Support as Consolidation ContinuesPCR Spike - thelegaladvocate.com
(OGN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Organon Audit Cleared And New Data Put Valuation And Risks In Focus - Yahoo Finance
Sun Pharma to Acquire Organon for $11.75 Billion in All-Cash Transaction - The Healthcare Technology Report.
Sun Pharma, Coforge: Indian businesses go shopping abroad as growth slows at home - BBC
Organon & Co. (OGN) Q1 2026 Earnings: EPS Falls Short of Estimates Amid Challenging Environment - thelegaladvocate.com
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration deal - The Economic Times
OGN Stock Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático - GlobeNewswire Inc.
Organon to supply Hanmi’s 3 combo drugs in Malaysia, Philippines - koreabiomed.com
What Sparked Organon's Recent Stock Surge - Kavout
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia - Macau Business
Organon (OGN) price target increased by 25.58% to 11.02 - MSN
10 Incredible Facts About Sun Pharma’s Historic $11.75 Billion Organon Acquisition - AOL.com
Organon & Co. (OGN) Leads Mid-Cap Stocks with Low Forward P/E Ra - GuruFocus
Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy - MSN
Organon & Co stock hits 52-week high at $13.44 By Investing.com - Investing.com Nigeria
Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN
Organon & Co stock hits 52-week high at $13.44 - Investing.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
1OGN.MI Stock Price, Quote & Chart | ORGANON & CO (BIT:1OGN) - ChartMill
Organon to Present New Research on Access and Value at ISPOR 2026 - BioSpace
Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN
Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN
Why is OGN stock rising in pre-market today? - MSN
Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN
Organon & Co. (NYSE:OGN) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Raises Stock Holdings in Organon & Co. $OGN - MarketBeat
BT explainer: Why Sun Pharma's $11.75-bn Organon deal is priced below past pharma acquisitions - MSN
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):